Ron Guiley OD, MPH, FAAO
There are lots of websites on macular degeneration, so why is MacularPatients.com different?
The standard mantra is that there’s no treatment for AMD. We believe the research actually suggests a number of treatments.
- We draw attention to the fact that a research-based set of macular degeneration causes exists now.
- Research has established that AMD is an inflammatory disease with extremely strong relationship to another inflammatory disease, cardiovascular disease.
- Many, if not most other inflammatory diseases like heart disease, diabetes and many others, have been shown to be reversible through epigenetic effects when sufficiently rigorous dietary and behavioral changes were undertaken.
- No such treatment study has ever been attempted for macular
- Today’s AMD patients don’t have time to wait for a study that may very well never come.
- If I had AMD, this is what I would do. I would want someone to interpret the current AMD research so I could at least figure out if I wanted to give treatment a serious try.
That’s why we’re here.
It is true we don’t know if the treatments we will discuss in our website, all based on studies in peer-reviewed medical and scientific journals, will work or not. And if they do work we don’t know how many patients will be helped and how many won’t.
Research is group-based. We do not advocate treatment for individuals. Take this information to your eye doctor and PCP to get their approvals.
The Researched-Based Triggers and Causes of Macular Degeneration
If you read any of the research summaries, this will now start to make sense.
This is based on the evidence from current published research on the causes of macular degeneration. So what about the treatment of macular degeneration?
In our next blog we’ll talk about the implications of this diagram on treatment of macular degeneration.
Macular Degeneration Treatment from the Experts
I count myself truly privileged to be able to directly communicate with Dr. Stuart Richer, Director of Ocular Preventive Medicine at the James Lovell Federal Health Care Facility and one of the world’s premier researchers on epigenetic treatment of macular degeneration.
If you read our Comprehensive Program for Macular Degeneration, you’re very familiar with his work.
Dr. Richer recently published a new, major literature review and it confirmed everything we’ve been writing about in our Comprehensive Program. Only this time Dr. Richer spent more time expanding on his knowledge about a slew of new research discussing different factors he sees as critical for macular degeneration patients.
So, with great pleasure our blogs/e-zines will start to discuss what’s most likely a collection of what researchers say are the most likely macular degeneration treatments to stabilize or improve vision.
A Macular Degeneration Treatment Summary for Busy People
Much as I hate to admit it, not everyone shares my interest in reading research summaries. If you are such a person, were going to soon offer a pared-down version of our in-depth Comprehensive Program for Macular Degeneration.
- If you want the steak with a bone in, go with the full Comprehensive Program.
- If you question where assumptions arise, the Comprehensive Program is for you.
- However, if you’re not terribly concerned about the published studies that underlie assumptions we make, and you only want lean, bite-size morsels, go with the Short and Sweet Program for Treating Macular Degeneration
We’ll be back with new information soon. If you want to receive our free and frequent email updates on new developments, sign up here.
Please let us know if you have comments or questions at email@example.com.
***If you are an eye doctor and have found this website, please send us your information and comments at firstname.lastname@example.org.
We wish you a successful journey.